Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 17 February 2009, doi:10.1136/bmj.b641
Cite this as: BMJ 2009;338:b641
| The first 100% of the full text of this article appears below. |
Ekeberg and colleagues in their carefully designed study provide further insight on the optimal approach for treating rotator cuff disease with steroid injections.1 However, the decision to also inject lidocaine into the shoulder of patients who received systematic treatment by means of corticosteroid injection in the gluteus is not without criticism.
It may achieve blinding for the test subject by partly neutralising the potential pain caused by corticosteroid injection of the shoulder in the localised injection group, but it also introduces new confounders. For example, short term relief of symptoms in the systemic group might be a result of a reduction of muscle spasms and tension caused by local lidocaine injection rather than the systemic corticosteroid injection.
Cite this as: BMJ 2009;338:b641
Karim Ochosi, associate professor of exercise science and sports medicine1
1 University of Puget Sound, Tacoma, WA 98416, USA
kochosi@ups.edu